June 14, 2026 08:31 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Tragedy in the skies: Five IAF personnel killed in AN-32 crash in Assam | 'Ask probe officers whether I hid anything': Abhishek Banerjee hits back after pre-dawn police search | Police storm Abhishek Banerjee's house at 3 am tracking aide, Mamata arrives; seizure list says 'NIL' | Big boost for India's security: DRDO successfully tests advanced missile shield | Indian-origin man jailed for 34 years in UK over horrific kidnap, torture and rape case | Mamata's nightmare deepens! Saayoni Ghosh, Dev, Rachana Banerjee among 19 rebel MPs seeking TMC split | Trump claims US 'ended war with Iran', Tehran yet to confirm a deal | Heartbreak for Indian sports: Manu Bhaker's mentor Jaspal Rana passes away at 49 | Three Indian seafarers, missing after US strike on tanker near Oman, confirmed dead | 'Choose your side': TMC MP Kalyan Banerjee's ultimatum to Mamata in open revolt against Abhishek
Delhi-Covaxin

No Covaxin doses for 18-44 years in Delhi from tomorrow

| @indiablooms | May 13, 2021, at 05:21 am

New Delhi/IBNS: People between the age group of 18-44 years will not get Covaxin doses in Delhi from Thursday as there is no stock of the Bharat Biotech developed vaccine left in the national capital.

The government has urged the central government to ensure uninterrupted supplies of vaccines, adding that Covishield stocks will last nine days.

There are four days of Covaxin left to be administered on frontline workers and those above 45.

The shots are essential for those who received the first dose around four weeks ago.

Earlier, Delhi Deputy Chief Minister Manish Sisodia has hit out at the Centre's vaccine management saying that Covaxin manufacturer Bharat Biotech has refused to supply the vaccine to the national capital.

Sisodia said Bharat Biotech has refused to supply the doses citing directives from the government and limited availability.

"Once again I would say exporting 6.6 crore doses was biggest mistake. We are forced to shut down 100 Covaxin-vaccination sites in 17 schools due to no supply," he wrote.

Sisodia said Delhi has asked for the supply of 1.34 crore doses, equal doses of Bharat Biotech's Covaxin and Serum Institute of India’s Covishield, to vaccinate the 18-44 age group.

Delhi entered the fourth week of lockdown on Monday, with stricter restrictions this time including the shutdown of the metro.

The national capital reported 13,287 new coronavirus cases and 300 more fatalities on Wednesday, while the positivity rate came down to 17 per cent.

India is currently reeling under the second wave of COVID-19 infections with around 3.5 lakh cases and 4,000 deaths being reported daily.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.